Caitlin Stein

Title: Caitlin Stein: Innovator in Antibody Development

Introduction

Caitlin Stein is a prominent inventor based in Clarkston, MI (US). She has made significant contributions to the field of biotechnology, particularly in the development of antibodies. Her work focuses on improving therapeutic options for various medical conditions.

Latest Patents

Caitlin holds a patent for "Antibodies targeting ActRIIA and ActRIIB." This patent describes antibodies and antibody fragments that are specific for ActRIIA and ActRIIB. The antibodies are enhanced versions of bimagrumab, featuring improved affinity against ActRIIA. This advancement translates into better in vitro potency and efficacy, along with an improved pharmacokinetic (PK) and pharmacodynamic (PD) profile. Additionally, these antibodies exhibit higher stability, making them suitable for subcutaneous (s.c.) administration. Some of the antibodies also carry Fc modifications, ensuring safety for prolonged treatments.

Career Highlights

Caitlin is currently associated with Six Peaks Bio, a company dedicated to advancing biopharmaceutical innovations. Her work at Six Peaks Bio has positioned her as a key player in the field of antibody research and development.

Collaborations

Caitlin collaborates with talented professionals in her field, including Christian Kunz and Amélie Wiederkehr. These collaborations enhance the research and development efforts at Six Peaks Bio.

Conclusion

Caitlin Stein's innovative work in antibody development showcases her commitment to advancing medical science. Her contributions are paving the way for new therapeutic options that could significantly impact patient care.